Akebia Therapeutics Inc.

NASDAQ: AKBA
Share price (1/8/25): $1.79
Market cap (1/8/25): $391 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Shelf registration

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

News Filter

Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Signs Commercial Supply Contract With Leading Dialysis Organization to Enable Access to Vafseo® (Vadadustat) for Patients on Dialysis

Material Definitive Agreement

Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Material Definitive Agreement, Termination of Material Definitive Agreement

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Scanned paper annual report submission